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Dominant negative effectHearing loss is a common communication disorder caused by various environmental and genetic factors.
Hereditary hearing loss is very heterogeneous, and most of such cases involve sensorineural defects in the
auditory pathway. There are currently 57 known autosomal dominant non-syndromic hearing loss (DFNA)
loci, and the causative genes have been identiﬁed at 22 of these loci. In the present study, we performed a
genome-wide linkage analysis in a Korean family segregating autosomal dominant hearing loss. We observed
linkage on chromosome 1p34, and at this locus, we detected a novel mutation consisting of an 18 nucleotide
deletion in exon 4 of the KCNQ4 gene, which encodes a voltage-gated potassium channel. We carried out a
functional in vitro study to analyze the effects of this mutation (c.664_681del) along with two previously
described KCNQ4 mutations, p.W276S and p.G285C. Although the c.664_681del mutation is located in the
intercellular loop and the two previously described mutations, p.W276S and p.G285C, are located in the pore
region, all mutants inhibit normal channel function by a dominant negative effect. Our analysis indicates that
the intercellular loop is as signiﬁcant as the pore region as a potential site of pathogenic effects on KCNQ4
channel function.+82 53 953 3066.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Potassium ions play a key role in sound transduction in the inner ear.
In the cochlea, a disparity of K+ concentration ismaintained between the
endolymphand the auditory cells in the scalamedia, and the sensory cells
have several types of K+ channels in their plasma membrane for K+
transport. An inﬂux of K+ across the concentration gradient from the
endolymph into the hair cells induces the neuronal signaling pathway.
Subsequently, K+ efﬂux from hair cells through other neighboring cells
returnsK+ to the endolymph. The recycling of K+and themaintenance of
homeostasis of the ion concentration in the cochlea has a crucial function
in the regulation of the excitability of hair cells, and the subsequent
neurotransmission pathway [1].
KCNQ4 is amember of the KCNQ family, which functions as voltage-
gated potassium channels in the membrane. Ion ﬂux through these
channels underlies theM current, and this gene is speciﬁcally expressed
in the outer hair cells (OHC) of cochlea [2–4]. Several previous studies
have identiﬁed mutations in the KCNQ4 gene that are responsible forautosomal dominant non-syndromic hearing loss (ADNSHL) [5–7], and
13 probable pathogenic mutations have been identiﬁed in this gene
associated with deafness that maps to the DFNA2 locus [8–16]. The
majority of studies have reported only the detection ofmutations in this
gene, without in vitro functional studies to help understand the
physiological effects of these mutations.
In this study, we describe a novel deletion mutation, c.664_681del in
the KCNQ4 gene as the cause of hearing loss in a Korean family with
deafness mapping to the DFNA2 locus. Furthermore, we performed
comparative in vitro functional studies to better understand the
pathogenic effects of c.664_681del mutation along with those of two
veriﬁedmissensemutations, p.W276S and p.G285C in this gene [17–19].
2. Materials and methods
2.1. Subjects
A four-generation Korean family with ADNSHL (KDF01) was
recruited from the Department of Otorhinolaryngology-Head and Neck
Surgery, Ajou University, Suwon, South Korea (Fig. 1). A total of 24
individuals including 11 affected and 13 unaffected members partici-
pated in this study. Physical and otoscopic examinations and
Fig. 1. Clinical information for KDF01 family with ADNSHL. a. Pedigree of KDF01 family. Squares and circles represent females and males. Affected individuals are denoted by solid
symbols and slash indicates a deceased individual. The affected haplotypes (rectangles) are co-segregated with DFNA2 locus on chromosome 1p34. Microsatellite markers were
selected according to their physical location on the human genome map (National Center for Biotechnology Information: www.ncbi.nlm.nih.gov). b. Audiogram for pure-tone
thresholds (PTA) of 11 affected individuals in the family. The average PTA value of right and left ears for each 11 patients was represented by the line graph, and the gray-zone
indicates the extent of normal auditory capacity. The numbers in the brackets are the ages of the members.
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(PTA). PTAwas calculatedasanaverageof the thresholdmeasuredat 0.5,
1.0, 2.0 and 3.0 KHz, and air-conduction threshold measurements wereperformed at 125–8000 Hz. The level of hearing loss is described as
follows depending on PTA: normal hearing, below 20 dB; mild hearing
impairment; 21 to 40 dB; moderate hearing impairment, 41 to 70 dB;
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impairment above 95 dB. In addition, bone conduction thresholds
were measured at 250–4000 Hz to exclude conductive hearing loss in
affected individuals. One hundred unrelated Koreans with normal
hearing were recruited as the normal control from Kyungpook National
University Hospital, Daegu, South Korea. All participants provided
written informed consent according to the protocol approved by the
Ethics Committee of Ajou University Hospital and Kyungpook National
University Hospital before the study. Genomic DNAs from the family
members and 100 controls were extracted from peripheral blood using
the FlexiGene DNA extraction kit (QIAGEN, Hilden, Germany).
2.2. Genetic analysis
A genome-wide linkage scan was carried out using 388 micro-
satellite markers from the ABI Prism LinkageMapping Set, version 2.5.
These markers have an average spacing of 10 cM across the genome.
Six additional markers in the 1p33–1p34.2 region were chosen from
the NCBI database (www.ncbi.nlm.nih.gov) to narrow down the
candidate region. Marker genotyping was performed by polymerase
chain reaction (PCR) using ﬂuorescently labeled primers with the
DNA Engine® Thermal cycler (BIO-RAD, Hercules, CA, USA), and the
products were analyzed on an ABI 3130xl genetic analyzer. Individual
genotypes for each marker were analyzed by using GeneMapper v4.0
software (Applied Biosystems Corp., Foster City, CA, USA).
Testing for errors in Mendelian inheritance was done using
PEDCHECK version 1.1 [20]. Two-point linkage analysis was per-
formed using the MLINK program within the LINKAGE software
package version 5.2 [21]. LOD scores were computed at different
recombination frequencies (θ), assuming equal recombination fre-
quencies in males and females. Analysis was performed under an
autosomal dominant model, with 99% penetrance and a disease allele
frequency of 0.001. In the candidate regions containing markers with
high LOD scores, haplotypes were constructed by genotyping
microsatellite markers in patients and other family members.
The entire coding region of KCNQ4was ampliﬁed using primer sets
designed using Primer 3 software (http://www-genome.wi.mit.edu/
cgi-bin/primer/primer3_www.cgi). The sequences of the coding
region obtained from direct sequencing were analyzed using an ABI
3130xl DNA sequencer (Applied Biosystems Corps., Foster City, CA,,
USA). Comparisons between family member DNA sequences and the
GenBank reference sequence of KCNQ4 (NM_004700.2) were per-
formed to deﬁne mutations in the KCNQ4 coding region.
2.3. Plasmid construction
A pCMV6 entry vector containing the KCNQ4 wild type full-length
cDNA C-terminally tagged with myc and ﬂag (Origene Technologies,
Rockville, MD, USA) was used for the functional studies. Mutant
plasmids containing the KCNQ4 cDNA mutagenized to c.664_681del,
c.827GNC (p.W276S) and c.853GNT (p.G285C) were constructed by
site-directed mutagenesis using pfu Taq polymerase (TaKaRa, Shiga,
Japan) and Dpn1 endonuclease (New England Biolabs, Ipswich, MA,
USA). Final sequences of the mutagenized cDNA inserted in the
plasmid were conﬁrmed by DNA sequencing.
2.4. Cell culture and transient transfection
The human embryonic kidney cell line HEK293 (American Type
Culture Collection, USA) was maintained in minimum essential
medium alpha (α-MEM) with 10% fetal bovine serum (WelGENE,
Daegu, Korea) and 1% penicillin (PAA Laboratories GmbH, Pasching,
Austria). Before transient transfection, cells were seeded to a density
of 50–70% conﬂuency on the 12 mm round coverslip for patch-clamp
and on the 100 mm culture dish for the biotinylation. For each
plasmid to be transfected, plasmid DNA and polyethyleneimine, PEI(Sigma Aldrich Corp., St. Louis, MO, USA) were mixed in the ratio of
1 μg to 3 μg in serum-free α-MEM media and incubated at room
temperature for 20 min. The plated cells were transfected with the
mixture and incubated at 37 °C for 24 h. In the case of transfection for
patch-clamp studies, the plasmid DNAwas co-transfected with pEGFP
N1 vector in the proportion of 1 μg plasmid to 50 ng pEGFP N1 vector
to discern transfected cells by ﬂuorescence.
2.5. Electrophysiology
One day after transfection, whole-cell voltage-clamp recordings
were performed from a single cell using an EPC10 ampliﬁer (HEKA
Elektronik, Germany) at room temperature (21–23 °C). Patch-clamp
pipettes were pulled from borosilicate glass and had a tip resistance of
2.5–4 MΩ when ﬁlled with pipette solution. The pipette solution
contained (inmM): 120 KCl, 5.4 CaCl2, 1.75MgCl2, 10 EGTA, 10 HEPES,
4 Mg-ATP, and 0.4 Na-GTP; pH was adjusted to 7.2 with KOH. The
external solution was constantly perfused (1–1.5 ml/min) with a
solution containing (in mM): 140 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, and 10
HEPES; adjusted to pH 7.4, with NaOH. The transfected cells were
detected with green ﬂuorescence via E enhanced green ﬂuorescent
protein (EGFP) expression. KCNQ4 currents were generated with
depolarizing voltage steps in 10 mV increments of 1.5 s duration from
a holding potential of −70 mV, followed by a constant potential of
−50 mV. Datawere sampled at 5 kHz and ﬁltered at 3 kHzwith Bessel
ﬁlter. Whole-cell K+ current was measured as the amplitude between
the steady state and peak. For calculating current density, the whole-
cell K+ current (pA) was divided by the cell capacitance (pF).
2.6. Cell surface biotinylation and western blotting
Expression of KCNQ4 protein on the cell surface was assayed by
biotinylation of cell surface protein. HEK293 cells transfected 24 h
previously with wild type or mutant type KCNQ4 were washed three
times with ice-cold PBS, and biotinylated with 0.5 mg/ml Sulfo-NHS-
SS-Biotin (Pierce Biotechnology Inc., Rockford, IL, USA) in PBS on ice
for 20 min. The reaction was quenched using 100 mM glycine in 1×
PBS for 20 min. After washing three times with ice-cold PBS, cells
were collected and suspended with lysis buffer (150 mMNaCl, 1% NP-
40, 0.1% SDS, 2 mM EDTA, 6 mM Na2HPO4, and 4 mM NaH2PO4)
containing the protease inhibitor PMSF (Benza and Leuptin), and
incubated on ice for 30 min. The whole-cell lysate was puriﬁed by
centrifugation at 12,000×g for 10 min (4 °C). To isolate biotinylated
proteins, 150 μl of streptavidin-coated agarose beads (Sigma Aldrich
Corp., St. Louis, MO, USA) was added to the puriﬁed lysate, and
incubated at 4 °C for 5 h with gentle rotation. The biotin–avidin
binding proteins were collected andwashed three timeswith the lysis
buffer. Sample buffer was added to the ﬁnal pellet and heated at
100 °C. The proteins were separated on 7.5% SDS-PAGE gel, and
transferred to nitrocellulose membranes. The blots were probed
overnight with mouse anti-FLAG® M2 antibody (1:1000 dilution;
Stratagene Corp., La Jolla, CA, USA) and goat anti-aldolase A antibody
(1:1000 dilution; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA)
at 4 °C. Detection of ﬂag and aldolase A was performed using goat
anti-mouse IgG-HRP and donkey anti-goat IgG-HRP (each 1:1000
dilution; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) at room
temperature for 1 h. Final protein bands were visualized by the
enhanced chemiluminescence, ECL solution (Amersham Biosciences,
USA) and exposed to X-ray ﬁlm. These experiments were repeated a
minimum of three times. The band intensities from western blotting
were calculated using Image J software (NIH, Bethesda, MD, USA), and
the values were normalized for each experiment. To determine the
signiﬁcance of differences between each wild and mutant type, the
data were analyzed by one-way ANOVA using SPSS software version
12.0 (SPSS Inc., Chicago, IL, USA). Only the results with a p-value of
less than 0.05 were considered to be statistically signiﬁcant.
Table 1




0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 Zmaxa θmax
D1S458 52.70 −5.00 0.28 0.66 0.80 0.84 0.80 0.72 0.60 0.44 0.84 0.20
D1S513 60.01 −4.31 −0.52 0.12 0.39 0.51 0.53 0.49 0.40 0.29 0.53 0.25
D1S432 69.86 1.28 1.75 1.68 1.50 1.26 0.98 0.69 0.40 0.17 1.75 0.05
D1S1188 70.41 0.64 1.24 1.32 1.29 1.20 1.08 0.92 0.73 0.52 1.32 0.10
D1S2722 72.59 1.08 2.27 2.42 2.35 2.17 1.91 1.59 1.23 0.82 2.42 0.10
D1S3721 72.59 3.59 3.32 3.04 2.74 2.43 2.10 1.74 1.36 0.94 3.59 0.00
a Zmax means a maximum LOD score for the marker in nine different recombination fractions (θ).
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3.1. Clinical features of the KDF01 family
The pedigree of the KDF01 family shows a typical autosomal
dominant inheritance pattern of hearing loss (Fig. 1a). Clinical
histories and audiological assays of the affected individuals revealed
a symmetrical, bilateral and progressive sensorineural hearing loss.
The earliest clinical evidence of hearing loss in this family was
obtained from individual IV-2 at the age of 4 years. The level of
hearing loss (HL) within the family showed variable presentation,
frommild to profound, and the severity of HL was proportional to age
[22]. Themajority of affected individuals showedmild or moderate HL
for low and mid frequencies, and severe HL for high frequencies
(Fig. 1b). The affected individuals had one of two audiogram patterns,
ﬂat or slopping, with most of the affected members displaying a
slopping audiogram. None of the affected individuals of the family
reported tinnitus, and none displayed clinical features of vestibular
dysfunction.
3.2. Linkage analysis and haplotype construction
A genome-wide linkage screen was performed using 388 micro-
satellite markers with an average spacing of 10 cM. Linkage analysis
revealed amaximum LOD score of 3.59 at recombination fraction 0.00,
obtained with marker D1S3721 on chromosome 1p34. Six additional
markers (D1S458, D1S513, D1S432, D1S2706, D1S1188 and D1S2722)
spanning 14.89 cM across the chromosome 1p34 regionwere selected
and genotyped to better delineate the candidate region. Although
D1S2706 was uninformative for linkage, the ﬁve other markers gave
positive LOD scores suggestive of linkage (Table 1).
The chromosome 1p haplotypes of the family were constructed
with seven microsatellite markers. One haplotype showed a signiﬁ-
cant LOD score at chromosome 1p34, and all the affected individualsFig. 2. Sequence analysis of exon 4 in KCNQ4 by TA cloning. A novel mutation causing deletion
family including II-1 were heterozygote for the mutation. In contrast, none of 13 norma
phenotype in the family.carried the same haplotype (Fig. 1a). Two informative recombination
events were identiﬁed in six affected individuals (II-1, II-4, III-1, III-9,
IV-1, and IV-2) and three unaffected individuals (II-3, II-8, and II-9).
The inspection of recombinant haplotypes in these nine subjects
placed the hearing loss locus between the markers D1S513 and
D1S2722. All of eleven affected individuals shared the same disease
haplotype, while none of the unaffected members carried this
haplotype. Thus, a region of approximately 12 cM on chromosome
1p34 between D1S513 and D1S2722 was deﬁned as the candidate
region responsible for hearing loss in this family. This candidate
region was coincident with that of the DFNA2 locus, an autosomal
dominant hearing loss locus that has been shown to contain two
causative hearing loss genes, GJB3 and KCNQ4.
3.3. Identiﬁcation of a novel mutation in KCNQ4 gene
The complete coding regions of the KCNQ4 and GJB3 genes were
analyzed in 24 KDF01 family members by direct sequencing. While no
mutations were identiﬁed in the GJB3 gene, we identiﬁed a novel
mutation in exon 4 of KCNQ4 gene in the affected members of this
family. The novel mutation was an 18 nucleotide deletion starting at
nucleotide position 664 (c.664_681del). This mutation is predicted to
cause the deletion of 6 amino acids in the intra-membrane loop
between S4 and S5 domains (Fig. 2). All of the 11 affected individuals
were heterozygous for this mutation, and none of the 13 normal
individuals in this family and 100 normal controls carried this
mutation.
3.4. Effects of mutations on KCNQ4 channel function
To determine the functional effects of mutations in the KCNQ4
channel, the channels were transiently expressed in HEK 293 cells and
whole-cell patch-clamp recordings were performed. Cells transfected
with the wild type KCNQ4 alone expressed well-deﬁned slow-activatingof 6 amino acids is detected in this mutation screening. Eleven affected members in the
l members had this mutation. The mutation genotypes were co-segregated with the
Fig. 3. Functional analysis of KCNQ4WT and KCNQ4MT (c.664_681del, p.W276S and p.G285C) in HEK293 cell line. a. Whole-cell membrane currents were recorded from transiently
transfected cells. From a holding potential of−70 mV, currents were evoked by depolarizing voltage steps from−70 mV to 50 mV in 10 mV increments. Scale bar denotes 500 ms
and 1 nA. b. Comparison of current–voltage relationships. Each point on the curves represents mean values of normalized peak current density at each voltage obtained from
recorded cells (n=number of cells tested). Curves of three mutant types alone were not represented because current values were measured to zero. c. Comparison of current
densities measured at +50 mV. †pb0.05, ††pb0.01 versus KCNQ4WT. **pb0.01 versus p.W276S+WT (1:1).
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(c.664_681del, p.G285C, and p.W276S) failed to display any detectable
K+ currents (Fig. 3a).We concluded that all three mutations cause a loss
of channel function. Because functional KCNQ channels are composed of
4 subunits,we examinedwhether themutant channels showadominant
negative effect as a heteromer containing both mutant and wild type
subunits. Whereas HEK293 cells co-transfected with wild type and
c.664_681del or p.G285C exhibited no currents, currents of about 32% of
wild type were detected in p.W276S co-transfected cells (Fig. 3). The
mean current density (pA/pF) of KCNQ4W276S:WT=1:1 at a +50 mV
voltage step was signiﬁcantly different from KCNQ4664_681del:WT=1:1,
andKCNQ4G285C:WT=1:1 (KCNQ4W276S:WT: 8.9±2.8, KCNQ4664_681del:WT:
2.3±0.7, and KCNQ4G285C:WT=1:1: 2.5±0.5, pb0.01, Newman–Keuls
post test). Taken together, these results indicate that heteromeric
channels containing c.664_681del or p.G285C subunits are nonfunction-
al, while heteromers of the wild type and p.W276S remain at some level
of functionality.
To estimate the effect of c.664_681del, p.W276S and p.G285C
mutations on the trafﬁcking of KCNQ4 to the plasma membrane, we
compared the KCNQ4 expression level in the whole cells with that in
plasma membranes by surface protein biotinylation method and
western blotting in HEK293 cells followed by statistical analysis. Co-
transfection of normal and mutant KCNQ4 cDNA was performed using
wild type and 3 mutant types of KCNQ4, to mimic the heterozygous
condition in patients with a dominantly inherited disease. In the
whole-cell lysate (cytoplasmic and surface-expressed), both the wildtype and 3mutant types of KCNQ4 showed no signiﬁcant difference in
quantitative expression, verifying that these three different mutations
have no inﬂuence on synthesis of the KCNQ4 protein (Fig. 4a).
Furthermore, this expression level was consistent with surface-
expressed KCNQ4. The three mutant KCNQ4 proteins showed
statistically equal expression with each other and with KCNQ4WT on
the cell surface as detected by biotinylation. Although there were a
little quantitative difference between the total and surface-expressed
protein in KCNQ4W276S (total 91±6.49, surface 108.25±7.26) and
KCNQ4G285C (total 104±16.17, surface 85.33±3.93), it was not
signiﬁcant (pN0.05). Upon co-expression of the wild type and each
mutant type, protein expression was not different from wild type
indicating that c.664_681del, p.W276S and p.G285C do not disturb
protein synthesis and polymerization of normal KCNQ4 channel
(Fig. 4b). Finally, our results suggest that these threemutations, which
occur in different regions of the protein, have no effect on the protein
synthesis and localization to the membrane, and that they disturb the
ion permeation through the pore by a dominant negative effect.
4. Discussion
In the present study, we used genetic studies of linkage analysis
and mutation screening to verify a novel pathogenic gene mutation in
a Korean family with dominantly inherited deafness. This mutation
was an 18 nucleotide deletion in the KCNQ4 gene, encoding a subunit
of voltage-gated potassium channel. KCNQ4 is normally expressed on
Fig. 4. Quantitative expression analysis of total and surface-expressed KCNQ4 protein. a. Western blot analysis of total and surface-expressed KCNQ4 protein. HEK293 cells were
transiently transfected with wild type (WT), mutant type, or co-transfected with wild type and mutant type (1:1). Whole-cell lysate and biotinylated proteins isolated by
streptavidin beads (surface) were subjected to western blot analysis. The over-expressed KCNQ4 monomers were detected at about 77 kDa, while non-transfected control cells
showed no signals. Cytoplasmic enzyme, aldolase A (40 kDa) was used as the intracellular control. All of 3 mutant types show quantitatively equal expression with the wild type in
the whole cell and surface. b. Expression levels quantiﬁed by densitometry were normalized for each experiment. Each bar indicates the mean values±SEM (standard error of the
mean) of at least 3 experiments. Black and white bars represent total KCNQ4 expressed in the whole cells and surface-expressed KCNQ4, each. Control indicates non-transfected
cells. All of 7 different types including the wild type and 3 mutants show practically equal expression. Also, statistical analysis using ANOVA demonstrated that no signiﬁcant
differences were detected between each type (pN0.05).
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monomer consists of 2 cytoplasmic domains, 6 trans-membrane
domains (S1–S6) including the voltage sensor (S4) domain, and a
pore domain between the S5 and S6 domains (Fig. 5a) [23]. The
functional KCNQ4 channel is composed of 4 subunits, and this channel
contributes to the homeostatic maintenance of K+ ions in the cochlea.
Kubisch et al. demonstrated that KCNQ4 is located within the DFNA2
locus and that mutations in this gene are causative of ADNSHL [2].
Since then, several subsequent studies have identiﬁed a total of 13
KCNQ4 gene mutations that have been suggested to cause ADNSHL.
Most of these 13 mutations are concentrated in the pore region of the
channel. The novel deletion mutation identiﬁed in this study,c.664_681del, is located in the S4–S5 loop region (Fig. 5a). This
suggests that the Korean population may be useful in expanding the
mutational spectrum observed in hereditary hearing loss, and that
such mutations may lead to a better understanding of the physiology
of KCNQ4 channels.
The roles of intracellular S4–S5 loops in regulation of channel
activation have been substantiated through various functional studies
for several types of K+ channels. Recently, several structural studies
for K+ channels, including shaker and hERG channels, demonstrated
that the S4–S5 linker region contributes to the gating of the channels
through the interaction with the distal portion of the S6 domain, and
that mutations in this region induce profound dysfunction of the
Fig. 5. Basic representation of the KCNQ4 protein. a. Schematic structure of KCNQ4 and the location of 13 mutations reported in previous studies. The KCNQ4 protein has 6 trans-
membrane domains and a pore region. Almost all of the previously described mutations are located in the pore region. The novel deletion mutation, c.664_681del identiﬁed in this
study is indicated with an asterisk. b. Multi-alignment for amino acid sequences in S4–S5 loop and pore region of the KCNQ family. Their sequences are highly conserved in both the
loop and pore regions. C.664_681del is outlined, and two pore mutations, p.W276S and p.G285C are denoted in bold.
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function of the other KCNQ family channels has also been demon-
strated. For example, Surti et al. (2005) veriﬁed that the activity of
KCNQ2/KCNQ3 channels is regulated by phosphorylation of a speciﬁc
residue located in S4–S5 loop [29]. In addition, studies of the KCNQ1
(KvLOT1) gene demonstrated that mutations in the S4–S5 loop region
cause a Long-QT syndrome [30–33]. The KCNQ1 mutation causing
Long-QT syndrome resides in the same region as the c.664_681del
identiﬁed in this study. In various voltage-gated K+ channels, the S4–
S5 linker plays a key role in the regulation of channel activity.
Moreover, this loop region is remarkably conserved across KCNQ
channels KCNQ1–KCNQ5 (Fig. 5b). This suggests that the
c.664_681del mutation of KCNQ4 has a profound effect on normal
channel function.
To demonstrate the effect of the c.664_681del mutation in the
living cells, we analyzed the channel expression and electrical activity
using biotinylation and patch-clamp methods. In addition, to
understand the roles of each domains in the KCNQ4 channel function,
comparative analysis for three mutations in the S4–S5 loop
(c.664_681del) and pore region (p.W276S and p.G285C) was
performed. Protein synthesis, trafﬁcking and membrane expression
of the channel were normal in all three mutant types. However, K+
ion ﬂow through membrane expressed KCNQ4 channels was not
detected in these three mutant KCNQ4 channels, indicating that
c.664_681del, p.W276S and p.G285C inhibit normal channel function
by a dominant negative effect. Mencia et al. (2008) reported that p.
G296S pore mutation of KCNQ4 impairs cell surface channel
expression. Although p.W276S and p.G285S are also pore mutations,p.W276S and p.G285S are located in WW motif and GYGD motif
which play the most important role in the potassium ion selectivity.
Especially, Uehara et al. (2008) veriﬁed that p.W309R mutation of
KCNQ3 does not impair normal surface expression of the channel, and
the position of p.W309R in KCNQ3 is equivalent to that of the p.W276
in KCNQ4 protein [34]. It suggests that the pathogenic effects of
p.W276S and p.G285C are likely due to loss of channel function, not
deﬁciency in protein synthesis or trafﬁcking.
Interestingly, two mutations, p.W276S and p.G285C showed
different magnitudes of the effect, although both mutations are
located in the pore region. In comparison, c.664_681del and p.G285C
showed a very strong dominant negative effect compared with p.
W276S, although they are located in different domains. However, the
disparity of the mutational effects in vitro did not correspond with
their clinical phenotypes in vivo. Although p.W276S and p.G285C
mutations showed different severity in the channel dysfunction,
patients with deafness carrying p.W276S or p.G285C mutation have
the same clinical symptoms, including onset ages, extension of onset
frequency, progression rate, and severity of the disease [19,35].
Although it is difﬁcult to understand the intricate in vivomechanisms
causing phenotypic characters as well as some differences between in
vitro and in vivo, we surmise that a slight difference in the degree of
molecular effect of these three pathogenic mutations is insufﬁcient to
provoke the phenotypic difference.
In conclusion, we identiﬁed a novel pathogenic mutation in the
KCNQ4 gene, and analyzed its physiological mechanisms for causing
hearing loss in a Korean family. This is the ﬁrst functional study of a
non-pore mutation in the KCNQ4 gene, and it veriﬁes that the S4–S5
543J.-I. Baek et al. / Biochimica et Biophysica Acta 1812 (2011) 536–543loop is as important as the pore region for channel function.
Furthermore, we investigated the interrelation between the muta-
tional effect at the molecular level and the phenotypic consequences
through a comparative study using other KCNQ4 gene mutations. This
exploration for naturally occurring defects in potassium channel
structure and function can provide valuable information for the
clariﬁcation of the etiological mechanisms of inherited hearing loss.
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